
Fertility prediction and insurance startup Gaia has raised $14 million in funding led by Peter Thiel’s Valar Ventures, as Axios reports. The round will support the company’s U.S. expansion, building on its 2022 London launch when it raised a $20 million Series A.
Founded with an initial focus on IVF, Gaia has expanded to include egg freezing, egg donation, and embryo batching. The company uses personal and fertility clinic data to predict treatment success probabilities and offers tiered financial protection plans where customers only pay full treatment costs upon achieving specific outcomes.
“The difference between you and me having a child is how rich you are,” founder Nader AlSalim told Axios. He added that “clinics still rely on calculators for financial planning. There’s so much low-hanging fruit to optimize before they can compete with us.”
The company operates across 57 locations through 23 clinic groups in the U.S., addressing a market where IVF treatment cycles typically cost between $15,000 and $25,000 with success rates of 25% to 40%. According to AlSalim, the company expects to raise additional funding within 18 months.